Clinical observation of 341 cases of COVID-19 infection treated with a Tibetan medicine combination regimen in plateau regions
DUO Jie-tai
GESANG Yun-dan
ZHANG Qiong-wen
PINGCUO Duo-ji
WANG Bao
SUOLANG Ren-qing
SANG Dan
SHEN Yan-ru
LI Yan-jun
REN Qing-jia
DANSONG Zha-ba
BIANBA Ci-ren
TANG Jian-yuan
CHEN Wei-wu
Abstract：Objective:To investigate the effect of Tibetan medicine combination regimen on the rates of negative nucleic acid conversion and symptom resolution in mild COVID-19 patients in plateau regions.Methods:A total of 653 patients were involved in the study and were assigned to either Tibetan medicine group(Cuitang granules+Liugan pills+Renqing Mangjue capsules+DasiMabao pills)or the Control group(no Tibetan medicine),based on theor willingness to received treatment.The rates of negative nucleic acid conversion and symptom remission were evaluated following the intervension.Results:There was no significant difference in the negative nucleic acid conversion rate and duration of residence between the Tibetan medicine and the Control group(no Tibetan medicine)(P＞0.05).However,the therapeutic effects of Tibetan medicine were better than those of Control group in alleviating symptoms of fever,cough,headache,dry pharyngeal pain,nasal congestion,fatigue and other related aspects(P＜0.01).Conclusion:The combination regimen of Tibetan medicine offers distinct advantages in relieving symptoms associated with novel coronavirus infection,including fever,cough,headache,sore throat and nasal congestion.
Keywords：combination of Tibetan medicineCOVID-19 infectionplateau areasclinical observation
Publication Date：2025-02-14
Online Publishing Date：2026-08-14(First online date of this platform, not the publication date of the document)
Pages：7( 275-281 )